Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Understanding the effect of alternative splicing in the folding and function of the second PDZ from protein tyrosine phosphatase-BL.

Di Silvio E, Toto A, Bonetti D, Morrone A, Gianni S.

Sci Rep. 2015 Mar 19;5:9299. doi: 10.1038/srep09299.

2.

Protein tyrosine phosphatases as potential therapeutic targets.

He RJ, Yu ZH, Zhang RY, Zhang ZY.

Acta Pharmacol Sin. 2014 Oct;35(10):1227-46. doi: 10.1038/aps.2014.80. Epub 2014 Sep 15. Review.

3.

The rates of protein synthesis and degradation account for the differential response of neurons to spaced and massed training protocols.

Naqib F, Farah CA, Pack CC, Sossin WS.

PLoS Comput Biol. 2011 Dec;7(12):e1002324. doi: 10.1371/journal.pcbi.1002324. Epub 2011 Dec 29.

4.

PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Freiss G, Chalbos D.

Anticancer Agents Med Chem. 2011 Jan;11(1):78-88. Review.

5.

Crystallographic and nuclear magnetic resonance evaluation of the impact of peptide binding to the second PDZ domain of protein tyrosine phosphatase 1E.

Zhang J, Sapienza PJ, Ke H, Chang A, Hengel SR, Wang H, Phillips GN, Lee AL.

Biochemistry. 2010 Nov 2;49(43):9280-91. doi: 10.1021/bi101131f.

6.

Nuclear APC.

Neufeld KL.

Adv Exp Med Biol. 2009;656:13-29. Review.

7.

[Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines].

Gur'ianova OA, Sablina AA, Chumakov PM, Frolova EI.

Mol Biol (Mosk). 2005 Sep-Oct;39(5):905-9. Russian.

8.
9.
10.

Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Kimber WA, Deak M, Prescott AR, Alessi DR.

Biochem J. 2003 Dec 1;376(Pt 2):525-35.

11.
12.
Items per page

Supplemental Content

Write to the Help Desk